We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
Cap. Flow
-$120M
Cap. Flow %
-6.62%
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497

Top Buys

Rank Stock Value
1
SHYG icon
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
+$24M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$7.59M
3
CZR
Caesars Entertainment Corporation
CZR
+$5.85M
4
AVGO icon
Broadcom
AVGO
+$5.1M
5
ACIA
Acacia Communications Inc
ACIA
+$3.72M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$16.1M
2
WBC
WABCO HOLDINGS INC.
WBC
+$11.4M
3
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$11.3M
4
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.3M
5
MU icon
Micron Technology
MU
+$8.71M

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Consumer Discretionary 5.02%
3 Healthcare 3.42%
4 Financials 2.97%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SILJ icon
1876
CALL
Amplify Junior Silver Miners ETF
SILJ
$3.85B
$1K ﹤0.01%
+100
New +$1K
SPRO icon
1877
Spero Therapeutics
SPRO
$73M
$1K ﹤0.01%
100
-600
-86% -$6.74K
STLA icon
1878
Stellantis
STLA
$20.8B
$1K ﹤0.01%
100
-10,816
-99% -$93.5K
SYNA icon
1879
Synaptics
SYNA
$4.15B
$1K ﹤0.01%
12
-908
-99% -$56.9K
TEVA icon
1880
CALL
Teva Pharmaceuticals
TEVA
$41.2B
$1K ﹤0.01%
100
-2,900
-97% -$32.8K
TPH
1881
DELISTED
Tri Pointe Homes
TPH
$1K ﹤0.01%
+100
New +$1.23K
TXMD icon
1882
CALL
TherapeuticsMD
TXMD
$24M
$1K ﹤0.01%
+14
New +$815
VKTX icon
1883
CALL
Viking Therapeutics
VKTX
$4B
$1K ﹤0.01%
+200
New +$1.33K
VNCE icon
1884
Vince Holding Corp
VNCE
$86.8M
$1K ﹤0.01%
+201
New +$1.11K
XFOR icon
1885
X4 Pharmaceuticals
XFOR
$460M
$1K ﹤0.01%
+3
New +$821
ENLC
1886
CALL
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$1K ﹤0.01%
+300
New +$620
TUP
1887
DELISTED
Tupperware Brands Corporation
TUP
$1K ﹤0.01%
+297
New +$988
SOLO
1888
CALL
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$1K ﹤0.01%
+600
New +$774
HALL
1889
DELISTED
Hallmark Financial Services, Inc.
HALL
$1K ﹤0.01%
+35
New +$1.17K
AMPE
1890
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1K ﹤0.01%
+7
New +$1.16K
NBEV
1891
CALL
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1K ﹤0.01%
400
-300
-43% -$448
XELA
1892
DELISTED
Exela Technologies, Inc. Common Stock
XELA
– –
0
– –
AFI
1893
DELISTED
Armstrong Flooring, Inc.
AFI
$1K ﹤0.01%
+389
New +$969
EVFM
1894
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1K ﹤0.01%
+20
New +$1.35K
EVFM
1895
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1K ﹤0.01%
+20
New +$1.35K
MGLN
1896
DELISTED
Magellan Health Services, Inc.
MGLN
$1K ﹤0.01%
+13
New +$832
JAX
1897
CALL
DELISTED
J. Alexander's Holdings, Inc.
JAX
$1K ﹤0.01%
+200
New +$909
KIN
1898
DELISTED
Kindred Biosciences, Inc.
KIN
$1K ﹤0.01%
+200
New +$894
KIN
1899
PUT
DELISTED
Kindred Biosciences, Inc.
KIN
$1K ﹤0.01%
+200
New +$894
HOME
1900
CALL
DELISTED
At Home Group Inc.
HOME
$1K ﹤0.01%
+200
New +$818
74 75
76
77 78

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.

  • Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
  • Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
  • Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
  • Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
  • Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
  • Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.